muTarget : A platform linking gene expression changes and mutation status in solid tumors-Reference-Cited by-同舟云学术

muTarget : A platform linking gene expression changes and mutation status in solid tumors

Published:2020-09-17 Issue:2 Volume:148 Page:502-511
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nagy Ádám¹²^ORCID,Győrffy Balázs¹²³

Affiliation:

1. Department of Bioinformatics Semmelweis University Budapest Hungary

2. Momentum Cancer Biomarker Research Group Research Centre for Natural Sciences Budapest Hungary

3. 2nd Department of Pediatrics Semmelweis University Budapest Hungary

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33283

Reference39 articles.

1. The current state of molecular testing in the treatment of patients with solid tumors, 2019

2. Distinguishing prognostic and predictive biomarkers: an information theoretic approach

3. Propagation on molecular interaction networks: prediction of effective drug combinations and biomarkers in cancer treatment;Ligeti B;Curr Pharm des,2017

4. Multi-omics approaches to disease

5. Network-based integration of multi-omics data for prioritizing cancer genes

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of GluN2B-Containing NMDA receptor antagonist for antitumor and antidepressant therapy in non-small cell lung cancer;European Journal of Pharmacology;2024-10

2. Integrated multi-omics profiling reveals a clinically relevant molecular feature and potential therapeutic target on phyllodes tumors of breast;Translational Oncology;2024-08

3. Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study;Discover Oncology;2024-06-07

4. Prediction of deleterious non-synonymous SNPs of human MDC1 gene: an in silico approach;Systems Biology in Reproductive Medicine;2024-04-17

5. The role of TAOK3 in cancer progression and development as a prognostic marker: A pan-cancer analysis study;Saudi Pharmaceutical Journal;2024-03